Viemed Healthcare Announces Share Repurchase Program Up to 5% of Outstanding Shares.
PorAinvest
lunes, 9 de junio de 2025, 8:21 am ET1 min de lectura
VMD--
Viemed plans to repurchase shares through various means, including open market purchases and block purchases, in accordance with applicable securities laws. Daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase, except for block purchases [1].
Casey Hoyt, the Chief Executive Officer of Viemed, highlighted the company's strong financial performance and commitment to shareholder value. He noted that the company's recent first quarter 2025 results and the increases in its 2025 guidance range midpoints demonstrate its robust execution and underlying fundamentals. Additionally, Viemed's track record of disciplined capital allocation, including the acquisition of Lehan's Medical, underscores its commitment to executing on its capital allocation strategies [1].
With no net debt and full availability on its $55 million credit facility, Viemed has ample liquidity to improve shareholder value through this share repurchase program while also funding its organic and inorganic growth initiatives [1].
The price paid for the common shares will be the market price at the time of purchase, plus applicable brokerage fees, or such other prices as may be permitted by applicable securities laws. The exact number of shares repurchased under the program cannot be guaranteed, and the company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The common shares purchased by the company will be cancelled [1].
References:
[1] https://www.morningstar.com/news/globe-newswire/9464872/viemed-healthcare-announces-share-repurchase-program
XYZ--
Viemed Healthcare, a national leader in in-home post-acute respiratory care, has announced a share repurchase program. The program will run through June 2026 and allows the company to purchase up to 1,976,441 common shares, or approximately 5% of the total issued and outstanding shares. Viemed plans to repurchase shares through open market purchases, block purchases, or other means in accordance with applicable securities laws.
Viemed Healthcare, Inc., a leading provider of in-home post-acute respiratory care, has authorized a share repurchase program that will run through June 2026. The program, announced on June 9, 2025, allows the company to purchase up to 1,976,441 common shares, which represents approximately 5% of the total issued and outstanding shares as of March 31, 2025 [1].Viemed plans to repurchase shares through various means, including open market purchases and block purchases, in accordance with applicable securities laws. Daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase, except for block purchases [1].
Casey Hoyt, the Chief Executive Officer of Viemed, highlighted the company's strong financial performance and commitment to shareholder value. He noted that the company's recent first quarter 2025 results and the increases in its 2025 guidance range midpoints demonstrate its robust execution and underlying fundamentals. Additionally, Viemed's track record of disciplined capital allocation, including the acquisition of Lehan's Medical, underscores its commitment to executing on its capital allocation strategies [1].
With no net debt and full availability on its $55 million credit facility, Viemed has ample liquidity to improve shareholder value through this share repurchase program while also funding its organic and inorganic growth initiatives [1].
The price paid for the common shares will be the market price at the time of purchase, plus applicable brokerage fees, or such other prices as may be permitted by applicable securities laws. The exact number of shares repurchased under the program cannot be guaranteed, and the company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The common shares purchased by the company will be cancelled [1].
References:
[1] https://www.morningstar.com/news/globe-newswire/9464872/viemed-healthcare-announces-share-repurchase-program

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios